AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20299481 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control subjects
Number of subjects: 761
Study 20299481 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement (e-mail)
Number of subjects: 761
Study 18545113 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC-201
Number of subjects: 688
Study 18545113 — intervention group
Group type: COMPARATOR
Intervention: PRBC
Number of subjects: 688
Study 18545113 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC-201 (HH)
Number of subjects: 688
Study 18545113 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC-201 (HR)
Number of subjects: 688
Study 15849530 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonblack race
Number of subjects: 780
Study 15849530 — intervention group
Group type: EXPERIMENTAL
Intervention: Being married
Number of subjects: 780
Study 15849530 — intervention group
Group type: EXPERIMENTAL
Intervention: Low SF‐36 mental health composite score
Number of subjects: 780
Study 15849530 — intervention group
Group type: EXPERIMENTAL
Intervention: >=2 prior PID episodes
Number of subjects: 780
Study 15849530 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 780
Study 15849530 — intervention group
Group type: COMPARATOR
Intervention: Histologic endometritis or evidence of endometrial Neisseria gonorrhoeae or Chlamydia trachomatis infection
Number of subjects: 780
Study 12693313 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted, intensified, multifactorial intervention
Number of subjects: 80
Study 12693313 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study 10503808 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational outreach visits by trained pharmacists delivering messages from four evidence-based clinical practice guidelines.
Number of subjects: 0
Study 10503808 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study 8686820 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary bladder temperature
Number of subjects: 0
Study 8686820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophageal temperature
Number of subjects: 0
Study 8686820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery temperature
Number of subjects: 0
Study 1881728 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric home care program (comprehensive biomedical and psychosocial care)
Number of subjects: 0
Study 1881728 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 6806218 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 rad daily to total tumor doses of 6000-7000 rad in 6-7 weeks
Number of subjects: 64
Study 6806218 — intervention group
Group type: COMPARATOR
Intervention: 400 rad daily to a total of approximately 4400 rad in 2-3 weeks
Number of subjects: 64
Study 31045501 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based, personalized webpage
Number of subjects: 99
Study 31045501 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 99
Study 30563042 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration H2 O2 exposure (2 hours)
Number of subjects: 0
Study 30563042 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentration H2 O2 exposure (2 hours)
Number of subjects: 0
Study 30563042 — intervention group
Group type: EXPERIMENTAL
Intervention: GOX treatments (low and high H2 O2 production rates)
Number of subjects: 0
Study 27350372 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Hypothermia (TH)
Number of subjects: 138
Study 27350372 — intervention group
Group type: COMPARATOR
Intervention: Strict Therapeutic Normothermia (STN)
Number of subjects: 138
Study 25017345 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle intervention (individual face-to-face and telephone sessions)
Number of subjects: 110
Study 25017345 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary and lifestyle intervention
Number of subjects: 110
Study 25017345 — intervention group
Group type: COMPARATOR
Intervention: Observational period (control)
Number of subjects: 110
Study 22460367 — intervention group
Group type: EXPERIMENTAL
Intervention: Group vocal improvement program (7 weekly lectures on anatomy, vocal hygiene, and vocal exercises)
Number of subjects: 37
Study 22460367 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained normal activities, no vocal improvement orientations)
Number of subjects: 37
Study 22460367 — intervention group
Group type: EXPERIMENTAL
Intervention: Group vocal improvement program
Number of subjects: 37
Study 19533238 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses without endoscopy assistance experience
Number of subjects: 30
Study 19533238 — intervention group
Group type: COMPARATOR
Intervention: Residents
Number of subjects: 30
Study 19533238 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses with endoscopy assistance experience
Number of subjects: 30
Study 19533238 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (residents and nurses)
Number of subjects: 30
Study 19533238 — intervention group
Group type: EXPERIMENTAL
Intervention: All trainee groups
Number of subjects: 30
Study 19533238 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents and nurses
Number of subjects: 30
Study 18338474 — intervention group
Group type: EXPERIMENTAL
Intervention: 15‐methyl PGF2alpha (125 microg) intramuscularly at the time of delivery of the anterior shoulder
Number of subjects: 100
Study 18338474 — intervention group
Group type: COMPARATOR
Intervention: Methylergometrine (0.2 mg) after delivery of placenta
Number of subjects: 100
Study 15665147 — intervention group
Group type: COMPARATOR
Intervention: Solving a puzzle during exercise
Number of subjects: 0
Study 15665147 — intervention group
Group type: EXPERIMENTAL
Intervention: Not solving a puzzle during exercise
Number of subjects: 0
Study 12357149 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 489
Study 12357149 — intervention group
Group type: EXPERIMENTAL
Intervention: Current plus ex-smokers
Number of subjects: 489
Study 10193676 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg three times a day)
Number of subjects: 9
Study 10193676 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg once a day)
Number of subjects: 9
Study 10193676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7479625 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐mg nicotine gum
Number of subjects: 56
Study 7479625 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 56
Study 2305995 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg tid (Group A)
Number of subjects: 62
Study 2305995 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFCA 30 mg tid (Group B)
Number of subjects: 62
Study 2305995 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 62
Study 2305995 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg tid (Group D, normal subjects)
Number of subjects: 62
Study 2305995 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFCA (both doses in Groups A and B)
Number of subjects: 62
Study 7000223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular cephradine 1 g 6-hourly for 48 hours
Number of subjects: 0
Study 7000223 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30475762 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized multi-modal digital health intervention targeting physical activity, nutrition, mental health, and cognitive training
Number of subjects: 8500
Study 28476133 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal brushing and standard oral and denture hygiene measures
Number of subjects: 52
Study 28476133 — intervention group
Group type: COMPARATOR
Intervention: Standard oral and denture hygiene measures
Number of subjects: 52
Study 25452069 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone continuing care program (ATIVR) for 4 months
Number of subjects: 158
Study 25452069 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 158
Study 23786948 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured lipid emulsion as parenteral alimentation
Number of subjects: 64
Study 23786948 — intervention group
Group type: COMPARATOR
Intervention: Physically mixed medium and long‐chain fat emulsion as parenteral alimentation
Number of subjects: 64
Study 23786948 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study 21698168 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-positive women (non-white)
Number of subjects: 2842
Study 21698168 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-positive women (non-smokers)
Number of subjects: 2842
Study 21698168 — intervention group
Group type: COMPARATOR
Intervention: HPV-negative women (non-smokers)
Number of subjects: 2842
Study 21698168 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-positive women (ex-smokers)
Number of subjects: 2842
Study 21698168 — intervention group
Group type: COMPARATOR
Intervention: HPV-negative women (ex-smokers)
Number of subjects: 2842
Study 19771403 — intervention group
Group type: EXPERIMENTAL
Intervention: 25U BoNT/A diluted in 2.5 ml sodium chloride solution (group I)
Number of subjects: 40
Study 19771403 — intervention group
Group type: COMPARATOR
Intervention: 25U BoNT/A diluted in 4 ml sodium chloride solution (group II)
Number of subjects: 40
Study 16532913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent bolus epidural analgesia (bupivacaine + fentanyl)
Number of subjects: 90
Study 16532913 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (bupivacaine + fentanyl)
Number of subjects: 90
Study 16532913 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (bupivacaine)
Number of subjects: 90
Study 16532913 — intervention group
Group type: COMPARATOR
Intervention: Groups receiving fentanyl (both patient-controlled and intermittent bolus)
Number of subjects: 90
Study 12770656 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with hyperbaric bupivacaine 1.5 mL 0.5%
Number of subjects: 60
Study 12770656 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration with a 50‐mL mixture containing 10 mL bupivacaine 0.5%, 10 mL prilocaine HCl 2%, and 30 mL isotonic solution with 1:200,000 epinephrine in combination with intravenous midazolam sedation
Number of subjects: 60
Study 11204034 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial filters for multichannel EEG
Number of subjects: 3
Study 8935302 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg, daily)
Number of subjects: 100
Study 8935302 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg, daily)
Number of subjects: 100
Study 8935302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (80 mg, daily)
Number of subjects: 100
Study 1585682 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomalt chocolate
Number of subjects: 162
Study 1585682 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol chocolate
Number of subjects: 162
Study 1585682 — intervention group
Group type: COMPARATOR
Intervention: No chocolate
Number of subjects: 162
Study 1585682 — intervention group
Group type: COMPARATOR
Intervention: Sucrose chocolate
Number of subjects: 162
Study 3156999 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 33
Study 3156999 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 33
Study 29606135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter
Number of subjects: 826
Study 29606135 — intervention group
Group type: COMPARATOR
Intervention: No fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h
Number of subjects: 826
Study 29606135 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 826
Study 26902403 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-resorptive (AR) combination of pomegranate fruit and grape seed extracts
Number of subjects: 3
Study 26902403 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone formation (BF) combination of quercetin and licorice extracts
Number of subjects: 3
Study 26902403 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of all four plant extracts (AR plus BF)
Number of subjects: 3
Study 25542635 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB) angioplasty
Number of subjects: 40
Study 25542635 — intervention group
Group type: COMPARATOR
Intervention: High-pressure balloon (HPB) angioplasty
Number of subjects: 40
Study 23465517 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP)
Number of subjects: 347
Study 23465517 — intervention group
Group type: COMPARATOR
Intervention: Watchful Waiting (WW)
Number of subjects: 347
Study 23465517 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 347
Study 21736705 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour
Number of subjects: 680
Study 21736705 — intervention group
Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 680
Study 19663089 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group (Acup.)
Number of subjects: 440
Study 19663089 — intervention group
Group type: COMPARATOR
Intervention: Prozac group (P.)
Number of subjects: 440
Study 16675182 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting posture (hip-flexed)
Number of subjects: 93
Study 16675182 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hip-flexed left lateral position (L)
Number of subjects: 93
Study 16675182 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hip-flexed right lateral position (R)
Number of subjects: 93
Study 16675182 — intervention group
Group type: COMPARATOR
Intervention: Supine 30 degrees lateral tilt (control group)
Number of subjects: 93
Study 15383854 — intervention group
Group type: EXPERIMENTAL
Intervention: Trisacryl gelatin microspheres (group A)
Number of subjects: 49
Study 15383854 — intervention group
Group type: COMPARATOR
Intervention: Polyvinyl alcohol particles (PVA) (group B)
Number of subjects: 49
Study 10917328 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge Examination (KE) and Mock Resuscitation (MR) at six months
Number of subjects: 43
Study 10917328 — intervention group
Group type: COMPARATOR
Intervention: Knowledge Examination (KE) only at six months
Number of subjects: 43
Study 10917328 — intervention group
Group type: COMPARATOR
Intervention: Mock Resuscitation (MR) only at six months
Number of subjects: 43
Study 10917328 — intervention group
Group type: COMPARATOR
Intervention: No intermediate testing
Number of subjects: 43
Study 9311050 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms beclomethasone dipropionate (BDP) combined with 200 micrograms salbutamol (group BDP-S, n = 9)
Number of subjects: 29
Study 9311050 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms salbutamol (group S, n = 8)
Number of subjects: 29
Study 9311050 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group P, n = 6)
Number of subjects: 29
Study 7974371 — intervention group
Group type: EXPERIMENTAL
Intervention: Allograft patients
Number of subjects: 0
Study 7974371 — intervention group
Group type: EXPERIMENTAL
Intervention: Autograft patients
Number of subjects: 0
Study 7974371 — intervention group
Group type: EXPERIMENTAL
Intervention: Allograft and Autograft patients
Number of subjects: 0
Study 2727646 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion of mediastinal blood (n = 67)
Number of subjects: 135
Study 2727646 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 68)
Number of subjects: 135
Study 2727646 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion group
Number of subjects: 135
Study 2727646 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 135
Study 8744 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (intravenous administration)
Number of subjects: 3
Study 30948503 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangminling pill
Number of subjects: 767
Study 28082454 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (head nurses received individual feedback)
Number of subjects: 445
Study 28082454 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 445
Study 25425710 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable oxygen concentrator
Number of subjects: 25
Study 25425710 — intervention group
Group type: COMPARATOR
Intervention: Combined system (fixed device with continuous-flow oxygen and portable device with pulse dispensation)
Number of subjects: 25
Study 25425710 — intervention group
Group type: COMPARATOR
Intervention: Combined system
Number of subjects: 25
Study 25425710 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 25
Study 24993861 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive leg raise (PLR) during CPR
Number of subjects: 3000
Study 24993861 — intervention group
Group type: COMPARATOR
Intervention: Flat position during CPR
Number of subjects: 3000
Study 22848157 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD-PS plus copd-6
Number of subjects: 9704
Study 22848157 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD-PS alone
Number of subjects: 9704
Study 22848157 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 9704
Study 20012446 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage (1 g of ethanol per kg bodyweight; vodka and orange juice)
Number of subjects: 10
Study 20012446 — intervention group
Group type: COMPARATOR
Intervention: Non-alcoholic beverage (orange juice)
Number of subjects: 10
Study 18281661 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel node dissection only
Number of subjects: 403
Study 18281661 — intervention group
Group type: COMPARATOR
Intervention: Sentinel node dissection
Number of subjects: 403
Study 15801939 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg bid for 7 days
Number of subjects: 20
Study 15801939 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diltiazem)
Number of subjects: 20
Study 12566365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 12566365 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 500 mg BID
Number of subjects: 305
Study 12566365 — intervention group
Group type: EXPERIMENTAL
Intervention: AGI‐1067 70 mg once daily
Number of subjects: 305
Study 12566365 — intervention group
Group type: EXPERIMENTAL
Intervention: AGI‐1067 140 mg once daily
Number of subjects: 305
Study 12566365 — intervention group
Group type: EXPERIMENTAL
Intervention: AGI‐1067 280 mg once daily
Number of subjects: 305
Study 10652637 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received verbal instructions with visual and auditory feedback during training sessions.
Number of subjects: 11
Study 10652637 — intervention group
Group type: COMPARATOR
Intervention: Control group received visual cueing about stance equilibrium and dynamic perturbations.
Number of subjects: 11
Study 9110190 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer display of high frame rate digital cineloops (47 frames/s)
Number of subjects: 25
Study 9110190 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer display of lower frame rate digital cineloops (24 frames/s)
Number of subjects: 25
Study 9110190 — intervention group
Group type: COMPARATOR
Intervention: Videotape recordings
Number of subjects: 25
Study 8374931 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol (320 mg/day)
Number of subjects: 30
Study 8374931 — intervention group
Group type: EXPERIMENTAL
Intervention: sotalol
Number of subjects: 30
Study 3534803 — intervention group
Group type: EXPERIMENTAL
Intervention: DHE 0.5 mg plus heparin 5000 U
Number of subjects: 888
Study 3534803 — intervention group
Group type: EXPERIMENTAL
Intervention: DHE 0.5 mg plus heparin 2500 U
Number of subjects: 888
Study 3534803 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin 5000 U
Number of subjects: 888
Study 3534803 — intervention group
Group type: EXPERIMENTAL
Intervention: DHE 0.5 mg
Number of subjects: 888
Study 3534803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 888
Study 30079962 — intervention group
Group type: EXPERIMENTAL
Intervention: NHO‐style vocal hygiene educational program
Number of subjects: 200
Study 30079962 — intervention group
Group type: COMPARATOR
Intervention: Control education program
Number of subjects: 200
Study 27181342 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Ananas comosus extract and honey (Bromelin®)
Number of subjects: 0
Study 27181342 — intervention group
Group type: COMPARATOR
Intervention: Honey alone (placebo group)
Number of subjects: 0
Study 24509551 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional needle rotation at LI10
Number of subjects: 22
Study 24509551 — intervention group
Group type: COMPARATOR
Intervention: Mock rotation at LI10
Number of subjects: 22
Study 22732831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic duct stent (PDS)
Number of subjects: 87
Study 22732831 — intervention group
Group type: COMPARATOR
Intervention: Guidewire (PDW)
Number of subjects: 87
Study 22732831 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PDS and PDW
Number of subjects: 87
Study 19608290 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 970
Study 18690309 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50mg (group T50)
Number of subjects: 60
Study 18690309 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100mg (group T100)
Number of subjects: 60
Study 18690309 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 60
Study 15965321 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated PET-CT imaging
Number of subjects: 173
Study 15965321 — intervention group
Group type: COMPARATOR
Intervention: CT with contrast
Number of subjects: 173
Study 14964319 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote audiometer operated via the Internet
Number of subjects: 45
Study 14964319 — intervention group
Group type: COMPARATOR
Intervention: Conventional audiometer
Number of subjects: 45
Study 10474558 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention over approximately 20 months
Number of subjects: 2519